Evaluation of Iodine Status among Korean Patients with Papillary Thyroid Cancer using Dietary and Urinary Iodine
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 최지연 | - |
dc.contributor.author | 이준협 | - |
dc.contributor.author | 송윤주 | - |
dc.date.accessioned | 2021-07-08T15:40:11Z | - |
dc.date.available | 2021-07-08T15:40:11Z | - |
dc.date.created | 2021-07-01 | - |
dc.date.issued | 2021-06 | - |
dc.identifier.issn | 2093-596X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/81639 | - |
dc.description.abstract | Background: Concerns have been raised regarding thyroid disorders caused by excessive iodine in Koreans, who have iodine-rich diets. This study evaluated iodine status using dietary iodine intake and urinary iodine in papillary thyroid cancer (PTC) patients. Methods: Dietary data of PTC patients were assessed using a 24-hour recall and food frequency questionnaire (FFQ), and urinary iodine concentrations (UICs) were also obtained. To compare the iodine status of PTC patients, Korean adults with or without thyroid disease from the Korea National Health and Nutrition Examination Survey, which had 24-hour recall data and urinary iodine measurements, were analyzed. Results: The median daily iodine intake by 24-hour recall was 341.7 μg/day in PTC patients, similar to the levels of other Korean adults. Based on UICs, the prevalence of excessive iodine was 54.4% in PTC patients, which was similar to the prevalence among subjects with thyroid disease (55.4%) but slightly higher than that in subjects without thyroid disease (47.7%). Based on dietary iodine by 24-hour recall, the prevalence of excessive iodine intake was 7.2%, which was higher than that among subjects with (4.4%) or without (3.9%) thyroid disease. The dietary iodine intake based on 24-hour recall was closely correlated with the UIC (r=0.4826) in PTC patients, but dietary iodine by FFQ was not significantly correlated with either 24-hour recall or UIC-based dietary iodine. Conclusion: Excessive iodine intake was more common in PTC patients than in subjects without thyroid disease. Further longitudinal research is necessary to elucidate the role of dietary iodine in PTC. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한내분비학회 | - |
dc.relation.isPartOf | Endocrinology and Metabolism | - |
dc.title | Evaluation of Iodine Status among Korean Patients with Papillary Thyroid Cancer using Dietary and Urinary Iodine | - |
dc.title.alternative | Evaluation of Iodine Status among Korean Patients with Papillary Thyroid Cancer using Dietary and Urinary Iodine | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000668158300016 | - |
dc.identifier.doi | 10.3803/EnM.2021.1005 | - |
dc.identifier.bibliographicCitation | Endocrinology and Metabolism, v.36, no.3, pp.607 - 618 | - |
dc.identifier.kciid | ART002728707 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85109728923 | - |
dc.citation.endPage | 618 | - |
dc.citation.startPage | 607 | - |
dc.citation.title | Endocrinology and Metabolism | - |
dc.citation.volume | 36 | - |
dc.citation.number | 3 | - |
dc.contributor.affiliatedAuthor | 이준협 | - |
dc.subject.keywordAuthor | Thyroid cancer | - |
dc.subject.keywordAuthor | papillary | - |
dc.subject.keywordAuthor | Thyroid diseases | - |
dc.subject.keywordAuthor | Iodine | - |
dc.subject.keywordAuthor | Dietary intake | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.